Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease.

MLA

Sen, H. M., et al. “Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease.” Balkan Journal of Medical Genetics : BJMG, vol. 17, no. 2, Apr. 2015, pp. 37–41. EBSCOhost, https://doi.org/10.2478/bjmg-2014-0072.

APA

Sen, H. M., Silan, F., Silan, C., Degirmenci, Y., & Ozisik Kamaran, H. I. (2015). Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease. Balkan Journal of Medical Genetics : BJMG, 17(2), 37–41. https://doi.org/10.2478/bjmg-2014-0072

Chicago

Sen, H M, F Silan, C Silan, Y Degirmenci, and H I Ozisik Kamaran. 2015. “Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease.” Balkan Journal of Medical Genetics : BJMG 17 (2): 37–41. doi:10.2478/bjmg-2014-0072.